Frovatriptan Succinate Patent Expiration
Frovatriptan Succinate is Used for the acute treatment of migraine attacks in adults. It was first introduced by Endo Operations Ltd
Frovatriptan Succinate Patents
Given below is the list of patents protecting Frovatriptan Succinate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Frova | US5464864 | Use of tetrahydrocarbazone derivatives as 5HT1 receptor agonists |
Nov 07, 2015
(Expired) | Endo Operations |
| Frova | US5827871 | Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof |
Oct 27, 2015
(Expired) | Endo Operations |
| Frova | US5637611 | Medicaments |
Jun 10, 2014
(Expired) | Endo Operations |
| Frova | US5616603 | Enantiomers of carbazole derivatives as 5-HT1 -like agonists |
Apr 01, 2014
(Expired) | Endo Operations |
| Frova | US5962501 | Enantiomer of carbazole derivative as 5-HT1-like agonists |
Dec 16, 2013
(Expired) | Endo Operations |
Frovatriptan Succinate's Family Patents
Explore Our Curated Drug Screens
Frovatriptan Succinate Generic API Manufacturers
Several generic applications have been filed for Frovatriptan Succinate. The first generic version for Frovatriptan Succinate was by Norvium Bioscience Llc and was approved on Aug 28, 2014. And the latest generic version is by Renata Ltd and was approved on Apr 6, 2022.
Given below is the list of companies who have filed for Frovatriptan Succinate generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 1 generic for Frovatriptan Succinate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Nov 6, 2018 |
2. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Frovatriptan Succinate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Mar 11, 2016 |
3. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Frovatriptan Succinate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Aug 28, 2014 |
4. RENATA
Renata Ltd has filed for 1 generic for Frovatriptan Succinate. Given below are the details of the strengths of this generic introduced by Renata.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Apr 6, 2022 |
Manufacturing Plant Locations New
Renata's manufacturing plants are situated in 5 countries - Brazil, United States, Hungary, Bangladesh, Poland. Given below are the details of these plant locations as well as the firm names of Renata as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Brazil |
| |||
| United States |
| |||
| Hungary |
| |||
| Bangladesh |
| |||
| Poland |
| |||